CO-IRBEWIN® 150/12,5


Tablets
scheduling status
S3
registration number
A40/7.1.3/0290
What CO-IRBEWIN® 150/12,5 contains
CO-IRBEWIN 150/12,5 tablets contain 150 mg of irbesartan and 12,5 mg hydrochlorothiazide.
other ingredients
Croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide and a film-coating.
Therapeutic classification
A 7.1.3 Other hypotensives.
© 2026 SAHPRA. ALL RIGHTS RESERVED